Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Intensive BP Arm
Standard BP arm
Sponsored by

About this trial
This is an interventional other trial for Hypertension focused on measuring Hypertension, Nighttime blood pressure
Eligibility Criteria
Inclusion Criteria:
- eligible and enrolled in SPRINT at the 27 month follow up visit
- able and willing to provide informed consent
Exclusion Criteria:
- arm circumference >50cm
- shift worker or work regularly at night
- history of breast cancer requiring mastectomy
- end-stage renal disease
Sites / Locations
- University of Alabama Birmingham
- Washington DC VA Medical Center
- Mayo Clinic
- Carolinas Medical Center
- Louis Stokes Cleveland VA Medical Center
- University of Pennsylvania
- Memphis VA
- Vanderbilt University
- Houston VA
- University of Utah
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Intensive BP Arm
Standard BP Arm
Arm Description
Participants randomized into the Intensive BP arm will have a goal of SBP <120mmHg. Drugs will be added and/or titrated at each visit (monthly) to achieve SBP <120 mmHg. At periodic "milepost" visits, addition of another drug will be "required" if not at goal.
Participants randomized into the Standard arm will have a goal of SBP <140 mm Hg. Intensify therapy if SBP ≥160 mmHg @ 1 visit; ≥140 mmHg @ 2 consecutive visits; Down-titration if SBP <130 mmHg @ 1 visit; <135 mmHg @ 2 consecutive visits.
Outcomes
Primary Outcome Measures
Nighttime systolic blood pressure
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. For the primary analysis, nighttime BP will be defined by narrow clock time (01:00 AM to 6:00 AM).
Secondary Outcome Measures
Night to day systolic BP ratio
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. The night to day systolic BP ratio will be calculated using narrow clock times.
Timing of peak BP
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. The timing of the peak BP will be calculated for each subject using cosinor rhythmometry analysis.
24hr average systolic BP
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. The average systolic BP will be calculated for each subject.
Blood pressure variability
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. Blood pressure variability will be defined by the standard deviation of the systolic blood pressure and by calculating the average real variability (ARV).
Full Information
NCT ID
NCT01835249
First Posted
April 16, 2013
Last Updated
January 23, 2019
Sponsor
University of Minnesota
Collaborators
Wake Forest University, Louis Stokes VA Medical Center, University of Pennsylvania, Carolinas Medical Center, Mayo Clinic, University of Utah, Vanderbilt University, University of Alabama at Birmingham, Michael E. DeBakey VA Medical Center, Memphis VA Medical Center, Washington D.C. Veterans Affairs Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT01835249
Brief Title
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
Official Title
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
June 2017 (Actual)
Study Completion Date
July 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota
Collaborators
Wake Forest University, Louis Stokes VA Medical Center, University of Pennsylvania, Carolinas Medical Center, Mayo Clinic, University of Utah, Vanderbilt University, University of Alabama at Birmingham, Michael E. DeBakey VA Medical Center, Memphis VA Medical Center, Washington D.C. Veterans Affairs Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hypertension is a major risk factor for cardiovascular and renal disease, and a leading cause of premature mortality worldwide. Early hypertension studies showed that treating elevated blood pressure (BP) reduces patients' risk of cardiovascular disease and all-cause mortality. In subsequent research, patients achieved greater improvement in cardiovascular outcomes when their treatment was aimed at a moderate systolic BP target (<150mmHg) than at higher targets. Although observational data suggest that even lower BP targets may be beneficial, this has not been seen in randomized trials; instead, "intense" treatment of hypertension (i.e., to a target systolic BP <120mmHg) was found to have no effect on participants' risk for renal disease, cardiovascular disease, or all-cause mortality.
One potential explanation for this apparent lack of benefit of intense BP targets is that the study protocols targeted reductions in clinic BP rather than ambulatory BP. Ambulatory BP monitoring (ABPM) allows for assessment of BP throughout the day and night. Of all the BP measurements, nighttime systolic BP appears to be the best predictor of cardiovascular disease and all-cause mortality. Because recent trials assessing intense BP targets did not include ambulatory BP measurements, the effect of intensive treatment on nighttime BP is largely unknown.
To address this important gap in knowledge, we will conduct ABPM in 600 participants as part of an ancillary study to the ongoing Systolic Blood Pressure Intervention Trial (SPRINT). The goal of the ancillary study is to evaluate the effect of intensive vs. standard clinic based BP targets on nighttime BP (primary outcome), as well as night/day BP ratio, timing of peak BP, 24hr BP, and BP variability (secondary outcomes). The SPRINT trial includes approximately 9250 participants at high risk for cardiovascular disease.
The investigators hypothesize that intense targeting of clinic systolic BP does not lower nighttime systolic BP compared to a standard target.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension, Nighttime blood pressure
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
897 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intensive BP Arm
Arm Type
Experimental
Arm Description
Participants randomized into the Intensive BP arm will have a goal of SBP <120mmHg. Drugs will be added and/or titrated at each visit (monthly) to achieve SBP <120 mmHg. At periodic "milepost" visits, addition of another drug will be "required" if not at goal.
Arm Title
Standard BP Arm
Arm Type
Active Comparator
Arm Description
Participants randomized into the Standard arm will have a goal of SBP <140 mm Hg. Intensify therapy if SBP ≥160 mmHg @ 1 visit; ≥140 mmHg @ 2 consecutive visits; Down-titration if SBP <130 mmHg @ 1 visit; <135 mmHg @ 2 consecutive visits.
Intervention Type
Other
Intervention Name(s)
Intensive BP Arm
Intervention Description
Participants in the Intensive arm have a goal of SBP <120 mmHg.
Intervention Type
Other
Intervention Name(s)
Standard BP arm
Intervention Description
Participants in the Standard BP arm have a goal of SBP <140 mmHg.
Primary Outcome Measure Information:
Title
Nighttime systolic blood pressure
Description
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. For the primary analysis, nighttime BP will be defined by narrow clock time (01:00 AM to 6:00 AM).
Time Frame
27 month follow up visit
Secondary Outcome Measure Information:
Title
Night to day systolic BP ratio
Description
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. The night to day systolic BP ratio will be calculated using narrow clock times.
Time Frame
27 month follow up visit
Title
Timing of peak BP
Description
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. The timing of the peak BP will be calculated for each subject using cosinor rhythmometry analysis.
Time Frame
27 month follow up visit
Title
24hr average systolic BP
Description
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. The average systolic BP will be calculated for each subject.
Time Frame
27 month follow up visit
Title
Blood pressure variability
Description
Ambulatory blood pressure monitoring will be performed within 3 weeks of the 27 month follow up visit. Blood pressure variability will be defined by the standard deviation of the systolic blood pressure and by calculating the average real variability (ARV).
Time Frame
27 month follow up visit
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
eligible and enrolled in SPRINT at the 27 month follow up visit
able and willing to provide informed consent
Exclusion Criteria:
arm circumference >50cm
shift worker or work regularly at night
history of breast cancer requiring mastectomy
end-stage renal disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul E Drawz, MD, MHS, MS
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alabama Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35294
Country
United States
Facility Name
Washington DC VA Medical Center
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20422
Country
United States
Facility Name
Mayo Clinic
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32224
Country
United States
Facility Name
Carolinas Medical Center
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28203
Country
United States
Facility Name
Louis Stokes Cleveland VA Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44129
Country
United States
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Facility Name
Memphis VA
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38104
Country
United States
Facility Name
Vanderbilt University
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37235
Country
United States
Facility Name
Houston VA
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
University of Utah
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
27849563
Citation
Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC Jr, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, Wall B, Wright JT, Rahman M. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension. 2017 Jan;69(1):42-50. doi: 10.1161/HYPERTENSIONAHA.116.08076. Epub 2016 Nov 14.
Results Reference
result
Learn more about this trial
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
We'll reach out to this number within 24 hrs